Member Info for Trickymatters

Confirmed on the sub title summary.
Talking about the faster technology again. Being interrupted about Moonshot. 'Given the stakes it is right that we invest very substantially '. We are expanding lab space rapidly here and overseas.

Sounds like he sees fast, poc antigen tests as the key to open up cultural and sporting life. 'Not quite there yet'. Hmm. ODX poc antigen tests scheduled for roll out by the end of the year. I totally see us in the mix with the 10 minute saliva test.

500,000 by the end of October. Challenge is capacity at the moment and substandard tests with too many false negatives and false positives. Plan for millions a day of better tests before the New Year. New approach to testing driven by the widespread experience of asymptomatic cases who are still spreading the virus.
Questions are very focused on now at the moment. No-one really digging into new plans.
Now moving onto worries about the economy related to the virus.

Rayofhope it's on BBC news channel. Not BBC 1.

Faz, didn't mention it- Hemo. So dunno. Don't follow them. Am keeping an eye on big covid stocks and CTEA. As comparators. Too busy keeping up with ODX :)

Their treatment is doing well in trials. You need antibodies from people who have recovered from cv19. Another future role for antibody tests.

Thx for your tip Swervington, my feet are very much on the ground thanks. I just said that the establishment (Tory grandee and the top public health commentators) are saying mass testing might be more realistically pitched at 2-3 million a day rather than 10 million. That's just the UK market. So feet on ground. But it's true I am capable of keeping up with the magnitude of the challenge posed by a global pandemic. My tip for you Swervy? Get your head out of the sand and pay close attention, lol.

Demand for testing is overwhelming. The media are being pretty relentless about it. Looks to me as if we will be coming down a little bit from the 10 million a day aspiration to 2 or 3 million? Jeremy Hunt said last night on channel 4 news that he thinks that would work. The Welcome Trust are saying the same thing- Francis Crick was on More or Less, radio 4 saying the same thing. He emphasised the importance of understanding prevalence to help target the right areas to recognise break outs and contain them. I can see a bigger order for the RTC at a better price than the discount agreed for the first 10 million. Higher price again for the Visitect antibody test and the antigen point of care when it's ready.
Loving the FT coverage about the weakness of the 20 nanosecond tests that were touted at Heathrow. ODX will sell everything it produces. 100 million capacity. Average price between £3 and £5 before operation Moonshot was announced. The market cap will be multiples of revenue. How many multiples depends on what sort of longevity the market gives to this leading diagnostics company. ODX have shown their adaptability in a world that will need constant innovation to manage pandemics. I think there will be international pressure to make sure we don't let providers in the field of public health lose traction. This will go ballistic within a couple of weeks. News will start piling in for us in days accompanied by wall to wall coverage. Aim high for your target price. The longer you stay in the bigger your rewards.

Plenty of CE marked tests have been pulled by PHE and/or MHRA. I don't need to have industry specific knowledge to understand that. The bottom line is that we are waiting for MHRA approval otherwise we would already be selling the RTC test. We aren't but we will.

Yeah and 2 million buys to 1 million sells showing. So God knows what that means? I would expect to see quite a big move up for that reason. Sigh. Our's is not to question why.

Chapsville, it doesn't need to be all centred around ODX. Although we do have 5 new generation tests that the whole of the UK are waiting for anxiously! We have capacity for 100 million tests and we will be flexible to meet demand. We will sell everything for between £3 and £5.00- maybe more. If the RTC sells at £13.00 we could easily be getting more than £5.00 for it. This share price is going up, up and away. Nothing that the trolls can do about it. I can't believe half of them are invested tbh. They come over as too sad for words.

Jim, totally. It's not because of Sneller that a few people are selling. It's because they hear Han**** say that we'll have new generation tests in a few weeks. Pretty dumb to sell for that reason. We will have one RNS after another because they will tell us about their preparations. CE marks for 2 tests are outstanding; transfer of the design freeze for the antigen poc from Mologic; the immunity report- REACT 2 part 4 will be out next week; self test report for the RTC; orders; contracts for orders and confirming additional sales options for the RTC; approval for the RTC test from the US; other overseas orders. We already know a lot of this is progressing very nicely. The sp will go up with each piece of news and once we get big news- immunity report; self test report from Ulster; orders and contracts it will fly. Trade if you want- at your own risk. You'll make a few quid and run the danger of getting locked out for the big money.

The link doesn't work Regulator. The laws you have quoted are out of date. There's a national procurement process set out on the MHRA and DHSC site. You don't have to meet the TPp specification- you will be 'held on file' in case advice changes. So not much good to anyone who wants to sell in the UK. We will need MHRA approval as stated in ODX RNS.

Regulator, MHRA have intervened to stop the sale of some tests in the UK so I assumed that would be a requirement? I think we would be flooded with poor quality tests otherwise. A CE mark is a quality standard but any qualifying body can award it can't they? Roche and Abbott had CE Mark's but they were withdrawn. We have already been CE marked and selected as preferred providers by dentists and some pharmacists but sales haven't started yet.

Visitect antibody test is a different test. They don't need to wait for government orders for that. Just waiting for MHRA approval.

Yeah. I suppose they might want it to coincide with the immunity report if it's going to be part of the mass testing program which I think is very likely. That's due next week. They have tested 100,000 health workers started on August 24th. It will all come together next week, one RNS after another for the RTC. But we also have an antigen test being trialled and assessed with Condor.

The 3 antibody spike test. 10 minutes. The tweet is really well designed. 'Rapid tests, anytime, anywhere '. Visitect (Omega 's own brand). Very interesting. It says: 'It's coming '. I guess they should know!

They only finished the ease of use test a week last Friday. They aren't working for the share price. They are working to produce a high quality report that will stand up to scrutiny. So that the test will be launched on the back of massive credibility.

All the new generation tests are going to sell out. Simple as that. 100 million capacity from ODX will sell out. Pricing at £1.50 to ODX for the first 10 million for government ( see investors presentation). After that £3-5 variable pricing for different tests. Next 10 days expect several RNS'. Looks like Elisa lab tests are still in high demand. We have 2 of those too. One antibody and one antigen. Then 3 poc tests with immediate results.
Massive pressure for testing. We will sell every test we make.

I logged out and in again and it's switched back to real time.